Advanced in Gilbert Syndrome

Matthew J. Armstrong

Birmingham, ENG, GB 
Advanced in Gilbert Syndrome
Birmingham, ENG, GB 
OverviewLocationsClinical Research

Overview

Matthew Armstrong practices in Birmingham, United Kingdom. Mr. Armstrong is rated as an Advanced expert by MediFind in the treatment of Gilbert Syndrome. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Alstrom Syndrome, Muscle Atrophy, and Liver Transplant.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Gilbert Syndrome.

Gender
Male

Locations

Birmingham, ENG, United Kingdom
Other Locations
London, ENG WC1E7HX, United Kingdom
Durham, ENG, United Kingdom
Newcastle Upon Tyne, ENG, United Kingdom
Bournemouth, ENG, United Kingdom
Edgbaston, ENG, United Kingdom
Poole, ENG, United Kingdom
Meridian Court, 5 Cadogan Street, Glasgow, SCT G26QE, United Kingdom
SCT, United Kingdom
Cambridge, ENG, United Kingdom
Manchester Royal Infirmary
Manchester, ENG, United Kingdom
Porchester Rd, Nottingham, ENG NG36LF, United Kingdom
Gyle Square, 1 South Gyle Crescent, Edinburgh, SCT EH129EB, United Kingdom
Oxford, ENG OX37LE, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
View 1 Less Clinical Trial

174 Total Publications

Increased quadriceps intermuscular adipose tissue in chronic liver disease is associated with an altered muscle transcriptome compared with healthy age matched controls.
Increased quadriceps intermuscular adipose tissue in chronic liver disease is associated with an altered muscle transcriptome compared with healthy age matched controls.
Journal: GeroScience
Published: October 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Armstrong's expertise for a condition
ConditionClose
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile